Trials / Conditions / Oral Squamous Cell Carcinoma (OSCC)

Oral Squamous Cell Carcinoma (OSCC)

15 registered clinical trials studyying Oral Squamous Cell Carcinoma (OSCC) — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Ora NCT07514767	Prof. Lars Olaf Cardell	Phase 2
Not Yet Recruiting	Effectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following F NCT07306546	Kaohsiung Medical University Chung-Ho Memorial Hospital	N/A
Recruiting	Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Car NCT07371611	Qunxing Li,MD	Phase 3
Not Yet Recruiting	A Prospective Single-Arm Study（NCLDR） NCT07028918	Qilu Hospital of Shandong University	EARLY_Phase 1
Not Yet Recruiting	Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advance NCT07137858	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2
Not Yet Recruiting	Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Ca NCT07079410	Shanghai Zhongshan Hospital	Phase 2
Not Yet Recruiting	Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer NCT06861712	Sun Yat-sen University	Phase 2
Recruiting	Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative NCT05774483	Tata Memorial Hospital	N/A
Not Yet Recruiting	Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy NCT06726512	University Medical Center Groningen	N/A
Not Yet Recruiting	Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cet NCT06728618	Shanghai Zhongshan Hospital	Phase 2
Not Yet Recruiting	Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction NCT06599801	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	—
Recruiting	A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC NCT07133958	Zhujiang Hospital	—
Unknown	Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population NCT04270201	Instituto do Cancer do Estado de São Paulo	—
Completed	Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab NCT07015333	Commonwealth Healthcare Corporation	—
Active Not Recruiting	A Dye for the Detection of Cancer of the Tongue and Mouth NCT03085147	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2